Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/11/2000 | CA2317113A1 Pharmaceutical composition having antitumor activity and process for the preparation thereof |
05/10/2000 | EP0998945A1 Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy |
05/10/2000 | EP0998944A2 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof |
05/10/2000 | EP0998943A1 A vitamine E acetate-based hydrophobic gel formulation for topical application |
05/10/2000 | EP0998942A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
05/10/2000 | EP0998935A1 Fatty emulsions containing reducing sugar and method for sterilizing the same |
05/10/2000 | EP0998933A1 Process for producing pharmaceutical compositions containing diphosphonates for oral administration |
05/10/2000 | EP0998932A1 Solid pharmaceutical dosage form containing diphosphonates or their salts and method for its production |
05/10/2000 | EP0998927A1 Absorption-enhancing composition for pantothenic acid derivative |
05/10/2000 | EP0998926A1 Oral preparation comprising S-(3-hydroxypropyl)-L-cysteine |
05/10/2000 | EP0998925A1 Medicinal compositions for topical administration containing vitamin d and vitamin k |
05/10/2000 | EP0998922A1 Aqueous coating composition and process for preparing solid pharmaceutical preparation |
05/10/2000 | EP0998921A1 Method and apparatus for manufacturing tablet capable of quick disintegration in oral cavity |
05/10/2000 | EP0998920A1 Method for producing solid dosage forms |
05/10/2000 | EP0998919A2 Solid dosage form with copolymeric binder |
05/10/2000 | EP0998918A2 Solid dosage form with copolymeric binder |
05/10/2000 | EP0998917A1 Preparation of biodegradable microparticles containing a biologically active agent |
05/10/2000 | EP0998916A1 Medicinal compositions for application to mucosa |
05/10/2000 | EP0998915A1 Use of silicon gum to stabilize ascorbic acid, and new compositions containing these compounds |
05/10/2000 | EP0998914A1 Composition to enhance permeation of topical skin agents |
05/10/2000 | EP0998903A1 Patch, assembly consisting of a patch and a container, and process |
05/10/2000 | EP0998886A1 Hot fomentations |
05/10/2000 | EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
05/10/2000 | EP0998565A1 Interleukin-3 gene therapy for cancer |
05/10/2000 | EP0998501A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
05/10/2000 | EP0998307A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
05/10/2000 | EP0998306A1 Liposomal compositions for the delivery of nucleic acid catalysts |
05/10/2000 | EP0998304A1 Pharmaceutical compositions comprising cyclodextrins |
05/10/2000 | EP0998303A1 Biologically active materials |
05/10/2000 | EP0998295A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients |
05/10/2000 | EP0998292A2 Method for inhibiting bone resorption |
05/10/2000 | EP0998289A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
05/10/2000 | EP0998279A1 Pharmaceutical injection solution containing taxol |
05/10/2000 | EP0998273A2 Osmotic delivery system flow modulator apparatus |
05/10/2000 | EP0998272A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
05/10/2000 | EP0998271A1 Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
05/10/2000 | EP0998270A1 Method and device for producing a multi-layer, physiologically tolerated presentation form |
05/10/2000 | EP0998269A2 Entrapping additives in carbohydrate bodies |
05/10/2000 | EP0998268A1 Powder compositions of unilamellar liposomes |
05/10/2000 | EP0998267A1 Internally supported lipid vesicle systems |
05/10/2000 | EP0998266A1 Microcrystalline cellulose: alginate pharmaceutical suspensions |
05/10/2000 | EP0998264A1 Composition comprising a lipoaminoacid and a tannin-rich plant extract |
05/10/2000 | EP0998251A2 Compositions and methods for inhibiting photoaging of skin |
05/10/2000 | EP0925065A4 Water miscible erythromycin solutions |
05/10/2000 | EP0797609B1 Polyesters |
05/10/2000 | EP0685234B1 Drug composition containing nucleic acid copolymer |
05/10/2000 | CN2376919Y Pile patch |
05/10/2000 | CN1252725A Analgesic combination |
05/10/2000 | CN1252721A Pharmaceutical composition |
05/10/2000 | CN1252720A Gastric-retained pharmaceutical compositions |
05/10/2000 | CN1252712A Use of micro particles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
05/10/2000 | CN1252711A Microemulsion |
05/10/2000 | CN1252710A Centre filled confectionery |
05/10/2000 | CN1252709A Confectionary compositions |
05/10/2000 | CN1252708A Throat soothing compositions |
05/10/2000 | CN1252705A Sustained analgesia achieved with buprenorphine |
05/10/2000 | CN1252310A Intensified gelatinized preparation |
05/10/2000 | CN1252308A Freeze-dried live attenuated hepatitis A vaccine and its preparation |
05/10/2000 | CN1252287A Hepatosis treating medicine and its preparation |
05/10/2000 | CN1252286A Medicine for pulmonary diseases and its preparation |
05/10/2000 | CN1252285A Preparation of AIDS resisting medicine from indian stringbush root extract |
05/10/2000 | CN1252284A Cancer treating bolus and its preparation process |
05/10/2000 | CN1252282A Royal jelly-bee glue powder capsule and its production process |
05/10/2000 | CN1252277A Quick soluble breviscapine B tablet and its preparation |
05/10/2000 | CN1252272A Plaster for beauty, medicine or skin science |
05/10/2000 | CN1052162C Production method of traditional Chinese medicine pills for hyperostosis |
05/09/2000 | US6060640 Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue |
05/09/2000 | US6060582 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
05/09/2000 | US6060557 Absorbing agents for water and aqueous liquids and process for their production and use |
05/09/2000 | US6060534 Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
05/09/2000 | US6060518 Polymer compositions for chemotherapy and methods of treatment using the same |
05/09/2000 | US6060513 Compounds and compositions for delivering active agents |
05/09/2000 | US6060512 Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging |
05/09/2000 | US6060474 Method for preventing scar tissue formation |
05/09/2000 | US6060461 Topically applied clotting material |
05/09/2000 | US6060455 Cationic and polycationic amphiphiles, reactives containing the same and their use |
05/09/2000 | US6060085 Dissolved drug that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a drug in a microparticulate state that does not readily cross the stratum corneum |
05/09/2000 | US6060084 Method for preparing a core material containment system and the core material containment system prepared thereby |
05/09/2000 | US6060082 Phospholipid bilayer having covalently bonded phospholipids, an aqueous core and a lectin wherein the lectin is ulex europeans agglutinin i. |
05/09/2000 | US6060081 Transporter is one or more di-c10-20 alkylamide glycylspermines. |
05/09/2000 | US6060080 Liposomal products |
05/09/2000 | US6060079 Device for topical localized administration of zinc to tissue |
05/09/2000 | US6060078 Chewable base contains an enhancing agent of chewing property selected from the group consisting of isomalt and liquid maltitol and a keeping agent of hardness and extension property being a gum including gelatin or arabic gum. |
05/09/2000 | US6060077 Unit galenical formulation for local hormonotherapy of vaginal dryness |
05/09/2000 | US6060069 Pulmonary delivery of pharmaceuticals |
05/09/2000 | US6060053 Injectable chondrocyte-carrier suspension for treatment of vesicoureteral reflux and incontinence |
05/09/2000 | US6060048 Method for transplanting cells into the brain and therapeutic uses therefor |
05/09/2000 | US6059913 Multilayer laminate |
05/09/2000 | CA2058940C Targeted liposomes and methods for liposome-protein coupling |
05/09/2000 | CA2030838C Preparations containing l-carnitine |
05/09/2000 | CA2019944C Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
05/09/2000 | CA2011532C Formulation |
05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
05/04/2000 | WO2000024785A1 Substance for reduction of cholesterol as well as lipids content |
05/04/2000 | WO2000024763A1 Single morphic forms of known peptide metalloproteinase inhibitors |
05/04/2000 | WO2000024452A1 Systems and compounds for drug delivery to interstitial regions of the myocardium |
05/04/2000 | WO2000024434A1 Vapour dispensing device |
05/04/2000 | WO2000024426A1 Ribozymes used as prodrugs |
05/04/2000 | WO2000024425A1 Preservative system for topically administrable pharmaceutical compositions |
05/04/2000 | WO2000024416A1 Remedies for bone metabolic errors |